Provided by Tiger Fintech (Singapore) Pte. Ltd.

Lineage Cell Therapeutics Inc

0.4900
-0.0083-1.67%
Post-market: 0.4800-0.0100-2.04%19:43 EDT
Volume:819.57K
Turnover:402.97K
Market Cap:111.89M
PE:-5.27
High:0.5138
Open:0.4941
Low:0.4647
Close:0.4983
Loading ...

Lineage Cell Therapeutics Announces Closing of Second Tranche of Previously Announced Registered Direct Offering

THOMSON REUTERS
·
28 Jan

Lineage Cell Therapeutics Is Maintained at Buy by Maxim Group

Dow Jones
·
11 Jan

Maxim Group Keeps Their Buy Rating on Lineage Therap (LCTX)

TIPRANKS
·
10 Jan

Down -43.14% in 4 Weeks, Here's Why Lineage Cell (LCTX) Looks Ripe for a Turnaround

Zacks
·
17 Dec 2024

Is Lineage (LINE) the Best New Pick in Brad Gerstner’s Portfolio?

Insider Monkey
·
03 Dec 2024

Lineage Cell Therapeutics Announces First Closing of up to $66 Million Registered Direct Offering

THOMSON REUTERS
·
22 Nov 2024

Lineage Cell (LCTX) Loses -26.3% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Zacks
·
21 Nov 2024

Lineage Cell Therapeutics tumbles after pricing $66M securities offering

seekingalpha
·
20 Nov 2024

BRIEF-Lineage Cell Therapeutics Announces Pricing Of Up To $66 Million Registered Direct Offering

Reuters
·
20 Nov 2024

Lineage Cell Therapeutics Announces Pricing of up to $66 Million Registered Direct Offering

THOMSON REUTERS
·
20 Nov 2024

Analysts Offer Insights on Healthcare Companies: Lineage Therap (LCTX), Veeva Systems (VEEV) and Takeda Pharmaceutical Company (TAK)

TIPRANKS
·
19 Nov 2024

Lineage Cell Therapeutics Initiated at Buy by D. Boral Capital

Dow Jones
·
18 Nov 2024

Lineage Cell Therapeutics initiated with a Buy at D. Boral Capital

TIPRANKS
·
18 Nov 2024

Lineage Cell Therapeutics Inc (LCTX) Q3 2024 Earnings Call Highlights: Strategic Advances and ...

GuruFocus.com
·
16 Nov 2024

Lineage Cell (LCTX) Reports Q3 Loss, Tops Revenue Estimates

Zacks
·
15 Nov 2024

Lineage Cell Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

THOMSON REUTERS
·
15 Nov 2024

Voyager Therapeutics (VYGR) Reports Q3 Loss, Tops Revenue Estimates

Zacks
·
13 Nov 2024